<DOC>
	<DOCNO>NCT01780207</DOCNO>
	<brief_summary>The purpose study patient obstructive sleep apnoea ( OSA ) concomitant patent foramen ovale ( PFO ) ass impact percutaneous PFO closure nocturnal hypoxemia apnea/hypopnea , pulmonary systemic artery pressure , endothelial function arterial stiffness .</brief_summary>
	<brief_title>Impact Of Closure Of Patent Foramen Ovale On Apnoea-Hypopnoea-Index , Nocturnal Hypoxemia And Systemic Vascular Function In Patients With Obstructive Sleep Apnoea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Foramen Ovale , Patent</mesh_term>
	<mesh_term>Anoxia</mesh_term>
	<criteria>Patients newly diagnose moderate severe OSA Age &gt; 17 year Written inform consent study participation . Patients pulmonary disease associate oxygen desaturation ( obesityassociated pulmonary restriction ) Patients central sleep apnea syndrome Patients cause pulmonary hypertension Intracardiac shunt via PFO Severe valvular heart disease Abnormal leave ventricular ( LV ) systolic function ( ejection fraction &lt; 50 % ) Obesity BMI &gt; 40 Contraindication TOE Severe pulmonary arterial hypertension ( mean pulmonary artery pressure &gt; 45 mmHg )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>